146 related articles for article (PubMed ID: 30279967)
1.
Contis-Montes de Oca A; Rodarte-Valle E; Rosales-Hernández MC; Abarca-Rojano E; Rojas-Hernández S; Fragoso-Vázquez MJ; Mendieta-Wejebe JE; Correa-Basurto AM; Vázquez-Moctezuma I; Correa-Basurto J
Oncotarget; 2018 Sep; 9(70):33368-33381. PubMed ID: 30279967
[TBL] [Abstract][Full Text] [Related]
2. Correction:
Contis-Montes de Oca A; Rodarte-Valle E; Rosales-Hernández MC; Abarca-Rojano E; Rojas-Hernández S; Fragoso-Vázquez MJ; Mendieta-Wejebe JE; Correa-Basurto AM; Vázquez-Moctezuma I; Correa-Basurto J
Oncotarget; 2019 Feb; 10(11):1225. PubMed ID: 30838095
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Evaluation of N-(2-hydroxyphenyl)-2-Propylpentanamide, a Valproic Acid Aryl Derivative with Activity Against HeLa Cells.
Luna-Palencia GR; Correa-Basurto J; Trujillo-Ferrara J; Meraz-Ríos MA; Vásquez- Moctezuma I
Curr Mol Pharmacol; 2021 Oct; 14(4):570-578. PubMed ID: 32744980
[TBL] [Abstract][Full Text] [Related]
4.
Sixto-López Y; Rosales-Hernández MC; Contis-Montes de Oca A; Fragoso-Morales LG; Mendieta-Wejebe JE; Correa-Basurto AM; Abarca-Rojano E; Correa-Basurto J
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824279
[No Abstract] [Full Text] [Related]
5. N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells.
Prestegui-Martel B; Bermúdez-Lugo JA; Chávez-Blanco A; Dueñas-González A; García-Sánchez JR; Pérez-González OA; Padilla-Martínez II; Fragoso-Vázquez MJ; Mendieta-Wejebe JE; Correa-Basurto AM; Méndez-Luna D; Trujillo-Ferrara J; Correa-Basurto J
J Enzyme Inhib Med Chem; 2016; 31(sup3):140-149. PubMed ID: 27483122
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation.
Mawatari T; Ninomiya I; Inokuchi M; Harada S; Hayashi H; Oyama K; Makino I; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Int J Oncol; 2015 Dec; 47(6):2073-81. PubMed ID: 26497673
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis.
Han BR; You BR; Park WH
Oncol Rep; 2013 Dec; 30(6):2999-3005. PubMed ID: 24064712
[TBL] [Abstract][Full Text] [Related]
8. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
Eikel D; Lampen A; Nau H
Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
[TBL] [Abstract][Full Text] [Related]
9. Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition.
Michaelis M; Suhan T; Reinisch A; Reisenauer A; Fleckenstein C; Eikel D; Gümbel H; Doerr HW; Nau H; Cinatl J
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3451-7. PubMed ID: 16123451
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells.
Aztopal N; Erkisa M; Erturk E; Ulukaya E; Tokullugil AH; Ari F
Chem Biol Interact; 2018 Jan; 280():51-58. PubMed ID: 29225137
[TBL] [Abstract][Full Text] [Related]
11. Characterization of valproic acid-initiated homologous recombination.
Sha K; Winn LM
Birth Defects Res B Dev Reprod Toxicol; 2010 Apr; 89(2):124-32. PubMed ID: 20437471
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors.
Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
J Pharmacol Exp Ther; 2019 Sep; 370(3):490-503. PubMed ID: 31308194
[TBL] [Abstract][Full Text] [Related]
13. Docking Studies of Glutamine Valproic Acid Derivative (S)-5- amino-2-(heptan-4-ylamino)-5-oxopentanoic Acid (Gln-VPA) on HDAC8 with Biological Evaluation in HeLa Cells.
Martínez-Ramos F; Luna-Palencia GR; Vásquez-Moctezuma I; Méndez-Luna D; Fragoso-Vázquez MJ; Trujillo-Ferrara J; Meraz-Ríos MA; Mendieta-Wejebe JE; Correa-Basurto J
Anticancer Agents Med Chem; 2016; 16(11):1485-1490. PubMed ID: 26845132
[TBL] [Abstract][Full Text] [Related]
14. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock.
Gonzales ER; Chen H; Munuve RM; Mehrani T; Nadel A; Koustova E
J Trauma; 2008 Sep; 65(3):554-65. PubMed ID: 18784568
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells.
Jeong SG; Ohn T; Kim SH; Cho GW
Neurosci Lett; 2013 Oct; 554():22-7. PubMed ID: 24021810
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells.
Yoon JY; Ishdorj G; Graham BA; Johnston JB; Gibson SB
Apoptosis; 2014 Jan; 19(1):191-200. PubMed ID: 24057147
[TBL] [Abstract][Full Text] [Related]
17. Opposing Effects of Valproic Acid Treatment Mediated by Histone Deacetylase Inhibitor Activity in Four Transgenic
Vent-Schmidt RYJ; Wen RH; Zong Z; Chiu CN; Tam BM; May CG; Moritz OL
J Neurosci; 2017 Jan; 37(4):1039-1054. PubMed ID: 28490005
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
Tarasenko N; Chekroun-Setti H; Nudelman A; Rephaeli A
J Cell Biochem; 2018 Apr; 119(4):3417-3428. PubMed ID: 29135083
[TBL] [Abstract][Full Text] [Related]
19. DNA Methylation Changes in Valproic Acid-Treated HeLa Cells as Assessed by Image Analysis, Immunofluorescence and Vibrational Microspectroscopy.
Veronezi GM; Felisbino MB; Gatti MS; Mello ML; Vidal BC
PLoS One; 2017; 12(1):e0170740. PubMed ID: 28114349
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid increases susceptibility to endotoxin shock through enhanced release of high-mobility group box 1.
Sugiura S; Ishihara Y; Komatsu T; Hagiwara M; Tanigawa N; Kato Y; Mizutani H; Kawahara K; Maruyama I; Noguchi T; Matsushita K
Shock; 2011 Nov; 36(5):494-500. PubMed ID: 21897334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]